4BIO Capital

March Biosciences is a clinical-stage cell therapy company that develops CAR-T cell strategies to address hematological cancers.

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.

Araris Biotech is a biotechnology platform enables the attachment of any payload to ‘off the shelf’ antibodies.

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

SparingVision is a biotechnology company developing genomic medicines for the treatment of blinding inherited retinal diseases.

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.